US coronavirus: Pfizer proposes expanding Covid-19 vaccine trial

One such candidate is in development by the American pharmaceutical company Pfizer, which announced along with its German partner BioNTech on Saturday they proposed expanding Phase 3 clinical trials to include 44,000 participants and more diverse patient populations, including people as young as 16. The proposal, which would need approval by the Food and Drug […]